StonvexLoading…
StonvexStonvexStonvexCore line items from ALRM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $265.19M | $1.01B | $749.53M | $493.13M |
Operating Income | $31.64M | $133.64M | $98.69M | $61.67M |
Net Income | $23.38M | $131.63M | $97.03M | $61.93M |
EPS (Diluted) | $0.47 | $2.46 | $1.80 | $1.15 |
Total Assets | $1.64B | $2.14B | $2.12B | $2.10B |
Total Liabilities | $739.85M | $1.25B | $1.24B | $1.25B |
Cash & Equivalents | $497.45M | $960.58M | $1.07B | $1.02B |
Free Cash Flow OCF − CapEx | $49.72M | $137.05M | $101.98M | $36.11M |
Shares Outstanding | 49.39M | 49.63M | 49.76M | 49.83M |